TrialTargeted oncology2021

A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers.

Jian Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.